InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: akhsv777 post# 46496

Wednesday, 04/03/2019 8:12:26 AM

Wednesday, April 03, 2019 8:12:26 AM

Post# of 48316
If the market is forward-looking then Oncosec should have a much higher market cap based on the prospects of their multi-gen construct. Immunotherapy is advancing and Oncosec is in a solid position to disrupt current markets in oncology. PISCES approval alone should get them to a much higher valuation. TNBC data in a few months, 25 patient data. TNBC could be very big for Oncosec if the data is decent. Early indications are that it will be good.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News